Literature DB >> 25637256

The effect of preoperative vitamin K on the INR in bridging therapy.

Ashrei Bayewitz1, Barbara Scorziello, Clarice Maala, Emily Giannattasio, Henny Heisler Billett.   

Abstract

We investigated a bridging protocol using oral Vitamin K three days before scheduled surgery. 60 patients in two bridging protocols, 30 cases per protocol. The first cohort (Control group) had its warfarin held on Day-5 (five days before surgery). The intervention cohort (Vitamin K group) routinely received 2.5 mg of oral Vitamin K on Day-3 but was otherwise identically bridged. Primary outcome was INR on Day-1. Secondary outcomes included patients with INRs ≥1.5 on Day-1, bleeding episodes and elevated INR post surgery. Day-1 INR for the Vitamin K group was 1.16, vs. 1.28 for the Control group (p = 0.037). Postoperative INR was similar. Only the Control group had patients with INRs ≥1.5 on Day-1, or patients with significant bleeding. Adding Vitamin K on Day-3 leads to a safe preoperative INR and may limit other complications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25637256     DOI: 10.1007/s12185-015-1744-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  11 in total

1.  Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.

Authors:  Mark A Crowther; Walter Ageno; Terri Schnurr; Elisa Manfredi; Krys Kinnon; David Garcia; James D Douketis
Journal:  Haematologica       Date:  2005-01       Impact factor: 9.941

2.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.

Authors:  David Garcia; John H Alexander; Lars Wallentin; Daniel M Wojdyla; Laine Thomas; Michael Hanna; Sana M Al-Khatib; Paul Dorian; Jack Ansell; Patrick Commerford; Greg Flaker; Fernando Lanas; Dragos Vinereanu; Denis Xavier; Elaine M Hylek; Claes Held; Freek W A Verheugt; Christopher B Granger; Renato D Lopes
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

4.  Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.

Authors:  S Schulman; J S Healey; J D Douketis; J Delaney; C A Morillo
Journal:  Thromb Res       Date:  2014-08-01       Impact factor: 3.944

5.  Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis.

Authors:  Francesco Dentali; Chiara Marchesi; Matteo Giorgi Pierfranceschi; Mark Crowther; David Garcia; Elaine Hylek; Daniel M Witt; Nathan P Clark; Alessandro Squizzato; Davide Imberti; Walter Ageno
Journal:  Thromb Haemost       Date:  2011-07-28       Impact factor: 5.249

6.  Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin.

Authors:  Karen Woods; James D Douketis; Kala Kathirgamanathan; Qilong Yi; Mark A Crowther
Journal:  J Thromb Thrombolysis       Date:  2007-03-23       Impact factor: 2.300

7.  Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.

Authors:  M J Kovacs; C Kearon; M Rodger; D R Anderson; A G G Turpie; S M Bates; L Desjardins; J Douketis; S R Kahn; S Solymoss; P S Wells
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

8.  Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K.

Authors:  Richard P Whitlock; Mark A Crowther; Theodore E Warkentin; Mary-Helen Blackall; Forough Farrokhyar; Kevin H T Teoh
Journal:  Ann Thorac Surg       Date:  2007-07       Impact factor: 4.330

9.  Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?

Authors:  A Steib; J Barre; M Mertes; M H Morel; N Nathan; Y Ozier; M Treger; C M Samama
Journal:  J Thromb Haemost       Date:  2009-11-12       Impact factor: 5.824

10.  Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study.

Authors:  Sam Schulman; Rajae Elbazi; Michelle Zondag; Martin O'Donnell
Journal:  Thromb J       Date:  2008-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.